Company profile for CSL Behring

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

CSL Behring is a global leader in the plasma protein biotherapeutics industry. We research, develop, manufacture and market biotherapies that are used to treat serious and rare conditions. Users of our therapies rely on them for their quality of life and, in many cases, for life itself. Our commitment to saving lives and improving the quality of life for people with serious and rare conditions is evident in everything we do. ...
CSL Behring is a global leader in the plasma protein biotherapeutics industry. We research, develop, manufacture and market biotherapies that are used to treat serious and rare conditions. Users of our therapies rely on them for their quality of life and, in many cases, for life itself. Our commitment to saving lives and improving the quality of life for people with serious and rare conditions is evident in everything we do. Whether we are manufacturing and marketing safe and effective products or researching and developing innovative biotherapies, we are first and foremost focused on fulfilling our customers’ needs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
HQ; 1020 First AvenueA
Telephone
Telephone
+1 610-878-4000
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.reuters.com/business/healthcare-pharmaceuticals/australias-csl-plans-invest-15-billion-us-plasma-therapy-expansion-2025-11-18/

REUTERS
18 Nov 2025

https://www.reuters.com/business/healthcare-pharmaceuticals/australias-csl-delays-vaccine-division-spin-off-amid-us-market-volatility-2025-10-27/

REUTERS
27 Oct 2025

https://www.prnewswire.com/news-releases/ispe-names-csl-behring-the-2025-ispe-facility-of-the-year-awards-foya-overall-winner-for-its-project-aurora-plasma-base-fractionation-facility-facility-f-302595608.html

PR NEWSWIRE
27 Oct 2025

https://www.fiercebiotech.com/biotech/sanofis-17b-rare-disease-bet-beats-csls-zemaira-phase-2-face

FIERCE BIOTECH
22 Oct 2025

https://www.pharmiweb.com/press-release/2025-10-07/csl-behring-signs-letter-of-intent-with-pan-canadian-pharmaceutical-alliance-pcpa-for-public-reimbursement-of-hemgenix-etranacogene-dezaparvovec

PHARMIWEB
07 Oct 2025

https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/csl-behring-716297-09092025

FDA
16 Sep 2025

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact CSL Behring and get a quotation

CSL Behring is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of Water bulk with CEP offered by CSL Behring

Find a price of ISCOMATRIX ADJUVANT bulk offered by CSL Behring

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty